This category lists trade associations or industry-driven cluster initiatives that I have done work for.

Benchmarked potentially competitive efforts in California, Massachusetts, Michigan, and Ohio as part of a comprehensive strategy on Autonomous Mobile Systems prepared by TEConomy Partners for the Regional Industrial Development Corporation and the Greater Pittsburgh Chamber of Commerce.

Benchmarked examples of other nations’ support for advanced-biomanufacturing initiatives, included in a report by TEConomy Partners for PhRMA, the Pharmaceutical Research and Manufacturers of America.

Assessed degree of alignment between investments made by Corporate Venture Capital affiliates of pharmaceutical companies and the firms’ core strategic interests, as part of a project by TEConomy Partners for PhRMA titled “Strengthening Biopharmaceutical Innovation: The Growing Role of Corporate Venture Capital.”

 

Conducted all benchmarking research for a report commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). The report highlights pro-innovation initiatives being undertaken by 18 nations (plus the European Union at the transnational level) that are challenging U.S. global leadership in the advanced biopharmaceutical industries. Work delivered as a subcontractor to TEConomy Partners.

Report cover

Cover page of the TEConomy Partners report for PhRMA. For the full report, click the image.

Conducted stakeholder interviews with the directors of four state associations which share certain interests with the New York State Economic Development Council (NYSEDC). Wrote an analytical summary of opportunities for alliances between these groups and NYSEDC, for use in strategic planning by the Executive Director and Executive Committee of the Board.

Benchmarked five major bioscience R&D institutes and several smaller programs for Indiana BioCrossroads (a cluster project of the Central Indiana Corporate Partnership) as part of a strategy project to design what became the Indiana Biosciences Research Institute.

BIOX_0000_IBRI-Report_cover

 

Benchmarked bioscience sectoral development strategies in 23 non-U.S. nations in a project on “growth platforms for economies around the world” for the Pharmaceutical Research and Manufacturers Association (PhRMA).

PhRMA Int

Conducted in-depth stakeholder interviews on possible reforms in the drug development pipeline as part of a project for the Council on American Medical Innovation, including also assessment of mechanisms used in other nations to promote biomedical innovation.

CAMI

Benchmarked bioscience cluster development strategies in more than 30 states as part of a project on “driving state economic growth” for the Pharmaceutical Research and Manufacturers Association (PhRMA).

PhRMA State

Conducted benchmark interviews with leaders of 10 world-leading research parks, as part of a first-of-its-kind study for the Association of University Research Parks.

Battelle-AURP-2007